Drug interactions for the following drug(s)
Cyclopentolate may increase the ulcerogenic activities of Potassium Chloride.
Drug1 (rxcui = 1298352, name = Cyclopentolate hydrochloride 10 MG/ML Ophthalmic Solution [AK-Pentolate], tty = SBD). Drug2 (rxcui = 315183, name = Potassium Chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug1 is resolved to Cyclopentolate, Drug2 is resolved to Potassium Chloride and interaction asserted in DrugBank between Cyclopentolate and Potassium Chloride.